Cargando…

Correction: Glaucoma, Alzheimer's Disease, and Parkinson's Disease: An 8-Year Population-Based Follow-Up Study

Detalles Bibliográficos
Autores principales:	Lin, I-Chan, Wang, Yuan-Hung, Wang, Tsung-Jen, Wang, I-Jong, Shen, Yun-Dun, Chi, Nai-Fang, Chien, Li-Nien
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2016
Materias:	Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4773249/ https://www.ncbi.nlm.nih.gov/pubmed/26930288 http://dx.doi.org/10.1371/journal.pone.0150789

Ejemplares similares

Glaucoma, Alzheimer's Disease, and Parkinson's Disease: An 8-Year Population-Based Follow-Up Study
por: Lin, I-Chan, et al.
Publicado: (2014)

The Role of Microglia in Retinal Neurodegeneration: Alzheimer's Disease, Parkinson, and Glaucoma
por: Ramirez, Ana I., et al.
Publicado: (2017)

Correction: Lin et al. Grounding the Body Improves Sleep Quality in Patients with Mild Alzheimer’s Disease: A Pilot Study. Healthcare 2022, 10, 581
por: Lin, Chien-Hung, et al.
Publicado: (2022)

Correction: Yao, C.A., et al. Soy-Based Multiple Amino Acid Oral Supplementation Increases the Anti-Sarcoma Effect of Cyclophosphamide. Nutrients 2016, 8, 192
por: Yao, Chien-An, et al.
Publicado: (2020)

Newly Diagnosed Anemia Increases Risk of Parkinson’s disease: A Population-Based Cohort Study
por: Hong, Chien Tai, et al.
Publicado: (2016)

Low LDL cholesterol, PCSK9 and HMGCR genetic variation, and risk of Alzheimer’s disease and Parkinson’s disease: Mendelian randomisation study
Publicado: (2017)

Correction: Links between COVID-19 and Parkinson’s disease/Alzheimer’s disease: reciprocal impacts, medical care strategies and underlying mechanisms
por: Huang, Pei, et al.
Publicado: (2023)

Correction: Predicting progression of Alzheimer's disease
por: Doody, Rachelle S, et al.
Publicado: (2010)

Correction: Hong et al. The Effect of Caffeine on the Risk and Progression of Parkinson’s Disease: A Meta-Analysis. Nutrients 2020, 12, 1860
por: Hong, Chien Tai, et al.
Publicado: (2023)

Correction to: Adaptive structural changes in the motor cortex and white matter in Parkinson’s disease
por: Fu, YuHong, et al.
Publicado: (2022)

Retinal Diseases and Parkinson Disease: A Population-Based Study
por: Chen, Po-Chih, et al.
Publicado: (2021)

Reduced vascular risk factors in Parkinson's disease dementia and dementia with Lewy bodies compared to Alzheimer's disease
por: Chan, Po‐Chi, et al.
Publicado: (2018)

Correction: Profiles of Extracellular miRNA in Cerebrospinal Fluid and Serum from Patients with Alzheimer's and Parkinson's Diseases Correlate with Disease Status and Features of Pathology
Publicado: (2014)

Microglial autophagy in Alzheimer’s disease and Parkinson’s disease
por: Wang, Zhifu, et al.
Publicado: (2023)

Association between Open-Angle Glaucoma and the Risks of Alzheimer’s and Parkinson’s Diseases in South Korea: A 10-year Nationwide Cohort Study
por: Moon, Jong Youn, et al.
Publicado: (2018)

Association Between Parkinson's Disease and Atrial Fibrillation: A Population-Based Study
por: Hong, Chien-Tai, et al.
Publicado: (2019)

Higher Serum DHA and Slower Cognitive Decline in Patients with Alzheimer’s Disease: Two-Year Follow-Up
por: Chu, Che-Sheng, et al.
Publicado: (2022)

Correction: A sialoadenectomy is associated with an increased risk of coronary heart disease: A three-year follow-up study
por: Hung, Shih-Han, et al.
Publicado: (2021)

Correction to: Comprehensive Management of Daily Living Activities, behavioral and Psychological Symptoms, and Cognitive Function in Patients with Alzheimer’s Disease: A Chinese Consensus on the Comprehensive Management of Alzheimer’s Disease
por: Jia, Jianjun, et al.
Publicado: (2021)

Plasma Exosomal Brain-Derived Neurotrophic Factor Correlated with the Postural Instability and Gait Disturbance–Related Motor Symptoms in Patients with Parkinson’s Disease
por: Chung, Chen Chih, et al.
Publicado: (2020)

Alzheimer's Disease and Glaucoma: Imaging the Biomarkers of Neurodegenerative Disease
por: Valenti, Denise A.
Publicado: (2011)

Neuropsychiatric Symptoms and Caregiver Stress in Parkinson’s Disease with Cognitive Impairment, Alzheimer’s Disease, and Frontotemporal Dementia
por: Chang, Yu-Tzu, et al.
Publicado: (2023)

Longitudinal follow-up study of the association with gout and Alzheimer’s disease and Parkinson’s disease in Korea
por: Lee, Eun Jae, et al.
Publicado: (2023)

Proton pump inhibitor use and the risk for Parkinson’s disease: A nationwide population-based study in Taiwan
por: Chen, Huan-Lin, et al.
Publicado: (2023)

Correction to: How relevant are social costs in economic evaluations? The case of Alzheimer’s disease
por: Peña-Longobardo, L. M., et al.
Publicado: (2021)

Correction to: Complement in the pathogenesis of Alzheimer’s disease
por: Paul Morgan, B.
Publicado: (2018)

Correction to: Comparison of neuropsychiatric symptoms and diffusion tensor imaging correlates among patients with subcortical ischemic vascular disease and Alzheimer’s disease
por: Tu, Min-Chien, et al.
Publicado: (2017)

Correction to: Proteomic landscape of Alzheimer’s Disease: novel insights into pathogenesis and biomarker discovery
por: Bai, Bing, et al.
Publicado: (2021)

Correction to: Knowledge and Attitudes of Two Latino Groups About Alzheimer Disease: A Qualitative Study
por: Cabrera, Laura Y., et al.
Publicado: (2023)

Increased Risk of Parkinson's Disease in Patients With Obstructive Sleep Apnea: A Population-Based, Propensity Score-Matched, Longitudinal Follow-Up Study
por: Yeh, Nai-Cheng, et al.
Publicado: (2016)

Correction to: Deciphering cellular transcriptional alterations in Alzheimer’s disease brains
por: Wang, Xue, et al.
Publicado: (2020)

Correction to: miRNAs and target genes in the blood as biomarkers for the early diagnosis of Parkinson’s disease
por: Liu, Xiaoting, et al.
Publicado: (2019)

Correction: Aryl hydrocarbon receptor regulates histone deacetylase 8 expression to repress tumor suppressive activity in hepatocellular carcinoma
por: Wang, Li-Ting, et al.
Publicado: (2018)

Correction: A Systematic Review of Biomarkers for Disease Progression in Alzheimer's Disease
Publicado: (2014)

Correction: Enhanced Functional Connectivity between Putamen and Supplementary Motor Area in Parkinson’s Disease Patients
por: Yu, Rongjun, et al.
Publicado: (2013)

Correction to: Metformin activates chaperone-mediated autophagy and improves disease pathologies in an Alzheimer disease mouse model
por: Xu, Xiaoyan, et al.
Publicado: (2021)

Correction: The Zinc Dyshomeostasis Hypothesis of Alzheimer's Disease
por: Craddock, Travis J. A., et al.
Publicado: (2012)

Correction: The Zinc Dyshomeostasis Hypothesis of Alzheimer's Disease
por: Craddock, Travis J. A., et al.
Publicado: (2012)

Correction: The Zinc Dyshomeostasis Hypothesis of Alzheimer's Disease
por: Craddock, Travis J. A., et al.
Publicado: (2013)

Correction: GWAS on family history of Alzheimer’s disease
por: Marioni, Riccardo E., et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_p7n1sjfvqee211prk7c11347q9